Ancom Nylex Expects Earnings Growth Moving Forward with MSMA Sales Recovery

Ancom Nylex Bhd is expected to experience earnings growth moving forward, driven by a significant increase in monosodium methanearsonate (MSMA) sales. The company is expected to secure Brazilian regulatory approvals to market MSMA beyond sugarcane applications, leading to higher volume growth of 15% in FY27. Tariff exemptions for timber preservative exports to the US and the contribution of a new agrochemical artificial intelligence (AI) product are also expected to boost earnings.